Cerubidine
(Daunorubicin Hydrochloride)Phase 3Small molecule
Daunorubicin is used to treat certain types of cancer, particularly leukemia and lymphoma, by killing cancer cells. It works by damaging cancer cell DNA so the cells cannot survive and spread.[1] Cerubidine is currently being investigated across 7 indications[3], with its most advanced program in Phase 3.[1]
Cerubidine is one of 112 small molecule programs targeting Acute Myeloid Leukemia. It is currently in Phase 3.
7
Indications
125
Total Trials
20
Active Trials
111
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
255 competitors in Acute Myeloid Leukemia
#DrugCompanyPhaseTrials
1Idamycin
PfizerPhase 3
Novantrone
PfizerPhase 3
Xospata
AstellasPhase 3
Fludara
SanofiPhase 3
Cerubidine
EEastern Cooperative Oncology Group
Phase 3
Vepesid
AAvyxa
Phase 3
Mylotarg
WWyeth-Lederle Vaccines
Phase 3
Vanflyta
Daiichi SankyoPhase 3
Neupogen
EEastern Cooperative Oncology Group
Phase 3
Cerubidine
HHikma Pharmaceuticals LLC
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Acute Lymphoblastic Leukemia43 trials
Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia
Recruiting·—·Phase 1·NCT05157971·24 enrolled
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Recruiting·—·Phase 2·NCT06918431·53 enrolled
Show 40 more trials
Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia
Unknown status·—·Phase 3·NCT00764907·4,000 enrolled
Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Completed·—·Phase 2·NCT00618501·50 enrolled
Acute Myeloid Leukemia42 trials
Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
Unknown status·EEuropean Organisation for Research and Treatment of Cancer - EORTC·Phase 3·NCT00004128·2,000 enrolled
Show 39 more trials
Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid Leukemia
Unknown status·IInstitut de Recherche Clinique sur les Cancers et le Sang·Phase 1·NCT00544999·21 enrolled
Leukemia10 trials
Show 7 more trials
Lymphoma4 trials
15 more indications
Myelodysplastic Syndrome3 trials
Myelodysplastic Syndromes3 trials
Acute Promyelocytic Leukemia2 trials
Lymphoblastic Lymphoma2 trials
B Acute Lymphoblastic Leukemia2 trials
Myeloproliferative Disorder1 trial
Chronic Myelogenous Leukemia1 trial
Core Binding Factor Acute Myeloid Leukemia1 trial
Untreated Adult Acute Myeloid Leukemia1 trial
T lymphoblastic leukemia/lymphoma1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Daunorubicin Hydrochloride. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details